Patrick Hervy

Catalent Maryland, Inc. engages in the manufactures of biopharmaceuticals products such as viral vectors, vaccines, and proteins and oncolytic viruses. It offers process development, GMP manufacturing, fill and finish, analytical development, master and working cell and virus banks, quality systems, and stabilities studies services. The company was founded by Marco A. Chacon in 1990 and is headquartered in Baltimore, MD.

For over a decade, XLHealth has been a leader in the development of programs and businesses that seek to improve healthcare for Medicare beneficiaries with special needs, such as those with chronic illnesses. Chronic illnesses such as diabetes and heart failure place a heavy burden on the elderly nearly 80 percent of all Medicare beneficiaries have at least one chronic health condition. In addition to the daily challenges of managing a chronic illness, beneficiaries with chronic health conditions account for a majority of healthcare spending. The costliest five percent of Medicare beneficiaries account for about half of all Medicare spending each year. Among this top five percent, approximately 47% have congestive heart failure and approximately 35% have diabetes. At XLHealth, they are dedicated to providing solutions that improve quality and reduce healthcare costs. Through their Medicare health plans, they have pioneered a specialized approach to healthcare coverage, with a range of benefits and services to fit a variety of healthcare and social support needs. For those with chronic health conditions integrating customized disease management support and